Cargando…
A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase
Influenza A virus (IAV) causes seasonal epidemics and occasional but devastating pandemics, which are major public health concerns. Because the effectiveness of seasonal vaccines is highly variable and the currently available drugs are limited in their efficacy because of the emergence of drug resis...
Autores principales: | Li, Ping, Cui, Qinghua, Wang, Lin, Zhao, Xiujuan, Zhang, Yingying, Manicassamy, Balaji, Yang, Yong, Rong, Lijun, Du, Ruikun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024319/ https://www.ncbi.nlm.nih.gov/pubmed/29899269 http://dx.doi.org/10.3390/v10060325 |
Ejemplares similares
-
Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase
por: Wang, Lin, et al.
Publicado: (2019) -
Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy
por: Zhao, Xiujuan, et al.
Publicado: (2022) -
A Recombinant Porcine Reproductive and Respiratory Syndrome Virus Stably Expressing a Gaussia Luciferase for Antiviral Drug Screening Assay and Luciferase-Based Neutralization Assay
por: Li, Yanhua, et al.
Publicado: (2022) -
A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes
por: Zhao, Xiujuan, et al.
Publicado: (2018) -
In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation
por: Luker, Kathryn E., et al.
Publicado: (2011)